Parexel International Corp (PRXL)-Financial and Strategic SWOT Analysis Review
January 2017
54
About the Report
About the Report
Parexel International Corp (PRXL)-Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company's businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company's key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.
The profile contains critical company information including:
Business description-A detailed description of the company's operations and business divisions.
Corporate strategy-Analyst's summarization of the company's business strategy.
SWOT Analysis-A detailed analysis of the company's strengths, weakness, opportunities and threats.
Company history-Progression of key events associated with the company.
Major products and services-A list of major products, services and brands of the company.
Key competitors-A list of key competitors to the company.
Key employees-A list of the key executives of the company.
Executive biographies-A brief summary of the executives' employment history.
Key operational heads-A list of personnel heading key departments/functions.
Important locations and subsidiaries-A list and contact details of key locations and subsidiaries of the company.
Key manufacturing facilities-A list of key manufacturing facilities of the company.
Detailed financial ratios for the past five years-The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
Interim ratios for the last five interim periods-The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.
Highlights
Parexel International Corp (Parexel) is a biopharmaceutical outsourcing services company which focuses on providing various services for managing the biopharmaceutical product lifecycle and for the development and commercialization of new medical therapies. It offers a comprehensive range of services including clinical trials management, observational studies and patient/disease registries, data management, biostatistical analysis, epidemiology, health economics/outcomes research, pharmacovigilance, medical communications, clinical pharmacology, patient recruitment, clinical supply and drug logistics, post-marketing surveillance, regulatory and product development and commercialization consulting among several others. Parexel caters its products and services to pharmaceutical, biotechnology and medical device industries worldwide. The company offers its services through a network of offices in various countries across the world. Parexel is headquartered in Waltham, Massachusetts, the US.
Parexel International Corp Key Recent Developments
Nov 14, 2016: PAREXEL Launches IDMP-Focused Software and Service Solution
Oct 26, 2016: PAREXEL International Reports First Quarter Fiscal Year 2017 Results and Announces New Share Repurchase Program
Oct 06, 2016: PAREXEL Launches Active Tracking Service for Monitoring and Managing Temperature-Controlled Investigational Medicinal Products
Sep 19, 2016: Christian Dreger Joins PAREXEL as Senior Vice President, PAREXEL Access and PAREXEL Consulting
Aug 03, 2016: PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results
Key benefits of buying this profile include:
You get detailed information about the company and its operations to identify potential customers and suppliers.
The profile analyzes the company's business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.
Understand and respond to your competitors' business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
The company's core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.
Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.
Scout for potential investments and acquisition targets, with detailed insight into the companies' strategic, financial and operational performance.
Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.
Gain key insights into the company for academic or business research.
Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.
Note: Some sections may be missing if data is unavailable for the company
Products
Products
Parexel International Corp, SWOT analysis, SWOT, Strengths, Weaknesses, Opportunities, Threats, Corporate Strategy, Key Ratios, Share Data, Performance, Financial Performance, Overview, Business Description, Major Product, Brands, History,Key Employees, Key Operational Heads, Strategy, Key Competitors, Company Statement, Capital Market Ratios, Financial Ratios, Annual Ratios, Interim Ratios, Ratio Charts
Companies
Worldwide Clinical Trials Drug Development Solutions Inc, Quintiles Transnational Holdings Inc, Quintiles Transnational Corp., Pharmaceutical Product Development LLC, Patheon Inc, Laboratory Corp of America Holdings, inVentiv Health Inc, INC Research LLC, ICON Plc, Covance Inc
Table of Contents
Table of Contents
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 5
Section 1-About the Company 6
Parexel International Corp-Key Facts 6
Parexel International Corp-Key Employees 7
Parexel International Corp-Key Employee Biographies 8
Parexel International Corp-Major Products and Services 9
Parexel International Corp-History 10
Parexel International Corp-Company Statement 16
Parexel International Corp-Locations And Subsidiaries 18
Head Office 18
Other Locations & Subsidiaries 18
Section 2-Company Analysis 23
Parexel International Corp-Business Description 23
Parexel International Corp-Corporate Strategy 24
Parexel International Corp-SWOT Analysis 25
SWOT Analysis-Overview 25
Parexel International Corp-Strengths 25
Parexel International Corp-Weaknesses 26
Parexel International Corp-Opportunities 27
Parexel International Corp-Threats 28
Parexel International Corp-Key Competitors 29
Section 3-Company Financial Ratios 30
Financial Ratios-Capital Market Ratios 30
Financial Ratios-Annual Ratios 31
Performance Chart 33
Financial Performance 33
Financial Ratios-Interim Ratios 34
Financial Ratios-Ratio Charts 35
Section 4-Company's Lifesciences Financial Deals and Alliances 36
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 36
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 37
Parexel International Corp, Recent Deals Summary 38
Section 5-Company's Recent Developments 39
Nov 14, 2016: PAREXEL Launches IDMP-Focused Software and Service Solution 39
Oct 26, 2016: PAREXEL International Reports First Quarter Fiscal Year 2017 Results and Announces New Share Repurchase Program 40
Oct 06, 2016: PAREXEL Launches Active Tracking Service for Monitoring and Managing Temperature-Controlled Investigational Medicinal Products 41
Sep 19, 2016: Christian Dreger Joins PAREXEL as Senior Vice President, PAREXEL Access and PAREXEL Consulting 42
Aug 03, 2016: PAREXEL International Reports Fourth Quarter and Fiscal Year 2016 Results 43
Aug 01, 2016: PAREXEL Appoints Four Executives to Senior Leadership Team 45
Jun 30, 2016: PAREXEL International Outlines Growth Strategy and Updates Financial Guidance at Investor Day 46
Jun 20, 2016: PAREXEL Experts to Discuss Key Drug Development Insights at DIA 2016 47
Jun 10, 2016: PAREXEL Announces Master Services Agreement with Pfizer 48
Apr 27, 2016: PAREXEL International Reports Third Quarter Fiscal Year 2016 Results 49
Section 6-Appendix 50
Methodology 50
Ratio Definitions 50
About GlobalData 54
Contact Us 54
Disclaimer 54
List of Figure
List of Figures
Parexel International Corp, Performance Chart (2012-2016) 33
Parexel International Corp, Ratio Charts 35
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 36
Parexel International Corp, Pharmaceuticals & Healthcare, Deals by Type, 2011 to YTD 2017 37
List of Table
List of Tables
Parexel International Corp, Key Facts 6
Parexel International Corp, Key Employees 7
Parexel International Corp, Key Employee Biographies 8
Parexel International Corp, Major Products and Services 9
Parexel International Corp, History 10
Parexel International Corp, Other Locations 18
Parexel International Corp, Subsidiaries 19
Parexel International Corp, Key Competitors 29
Parexel International Corp, Ratios based on current share price 30
Parexel International Corp, Annual Ratios 31
Parexel International Corp (Cont...1), Annual Ratios 32
Parexel International Corp, Interim Ratios 34
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Year, 2011 to YTD 2017 36
Parexel International Corp, Pharmaceuticals & Healthcare, Deals By Type, 2011 to YTD 2017 37
Parexel International Corp, Recent Deals Summary 38
Currency Codes 50
Capital Market Ratios 50
Equity Ratios 51
Profitability Ratios 51
Cost Ratios 52
Liquidity Ratios 52
Leverage Ratios 52
Efficiency Ratios 53
Why Buy From US?
What makes us stand out is that our consultants follows Robust, Refine and Result (RRR) methodology. i.e. Robust for clear definitions, approaches and sanity checking, Refine for differentiating respondents facts and opinions and Result for presenting data with story
We have set a benchmark in the industry by offering our clients with syndicated and customized market research reports featuring coverage of entire market as well as meticulous research and analyst insights.
While we don't replace traditional research, we flip the method upside down. Our dual approach of Top Bottom & Bottom Top ensures quality deliverable by not just verifying company fundamentals but also looking at the sector and macroeconomic factors.
With one step in the future, our research team constantly tries to show you the bigger picture. We help with some of the tough questions you may encounter along the way: How is the industry positioned? Best marketing channel? KPI's of competitors? By aligning every element, we help maximize success.
Our report gives you instant access to the answers and sources that other companies might choose to hide. We elaborate each steps of research methodology we have used and showcase you the sample size to earn your trust.
If you need any support, we are here! We pride ourselves on universe strength, data quality, and quick, friendly, and professional service.